Author Correction: AZD9291 inactivates the PRC2 complex to mediate tumor growth inhibition

Authors: Kai-li Zhang1,2, Qian-qian Shen1, Yan-feng Fang1, Yi-ming Sun1, Jian Ding1, Yi Chen1
1 Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
2 University of Chinese Academy of Sciences, No.19A Yuquan Road, Beijing 100049, China
Correspondence to: Jian Ding:, Yi Chen:,
DOI: 10.1038/s41401-019-0344-3
Advance online: 14 February 2019


After publication, the authors realized that the western blotting bands of EZH2 (Fig. 2a), and β-actin (Fig. 2a, Fig. 3a) in MDA-MB-453 cells were misplaced. And in Fig. 5c, the representative images of miR-NC group cells were found to be misplaced by accident. The correct figures are reproduced and presented. The conclusions are not affected by this correction. We sincerely apologize for our mistakes and any inconvenience this might have caused.
Keywords: N/A

Article Options

Download Citation

Cited times in Scopus